Solara Active Pharma Sciences Limited (BOM:541540)
India · Delayed Price · Currency is INR 615.60
-22.50 (-3.53%)
At close: Aug 21, 2026
Solara Active Pharma Sciences Employees
Solara Active Pharma Sciences had 1,775 employees as of March 31, 2025. The number of employees decreased by 381 or -17.67% compared to the previous year.
Employees
1,775
Change (1Y)
-381
Growth (1Y)
-17.67%
Revenue / Employee
8.06M INR
Profits / Employee
-9.13K INR
Market Cap
29.72B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 1,775 | -381 | -17.67% |
| Mar 31, 2024 | 2,156 | -205 | -8.68% |
| Dec 31, 2023 | 2,205 | -156 | -6.61% |
| Mar 31, 2023 | 2,361 | 107 | 4.75% |
| Mar 31, 2022 | 2,254 | -321 | -12.47% |
| Jun 30, 2021 | 2,500 | 104 | 4.34% |
| Mar 31, 2021 | 2,575 | 179 | 7.47% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IOL Chemicals and Pharmaceuticals | 3,095 |
| Neuland Laboratories | 2,183 |
| Shilpa Medicare | 998 |
| Bajaj HealthCare | 918 |
| NGL Fine-Chem | 498 |
| Sai Parenteral's | 296 |
| Gujarat Themis Biosyn | 221 |
| Influx Healthtech | 163 |
Solara Active Pharma Sciences News
- 4 months ago - Solara Active Pharma share price jumps over 4% after USFDA closes Puducherry facility inspection with VAI status - Business Upturn
- 9 months ago - Solara Active Pharma’s Mangalore facility clears US FDA inspection with VAI classification - Business Upturn
- 10 months ago - Solara Active Pharma shares slump nearly 9% today after reporting Q2 net loss - Business Upturn
- 1 year ago - Solara Active Pharma shares rise 4% after Ambernath facility clears USFDA inspection with zero observations - Business Upturn
- 1 year ago - Solara Active Pharma shares down 5% as Managing Director Poorvank Purohit resigns - Business Upturn
- 1 year ago - Solara Active Pharma Sciences announces demerger of CRAMS and Polymers business - Business Upturn
- 1 year ago - Solara Active Pharma Sciences Q3 FY25 Results: Revenue up 41.6% YoY to Rs 300.31 crore - Business Upturn